Compare BLBD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLBD | RXRX |
|---|---|---|
| Founded | 1927 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2013 | 2021 |
| Metric | BLBD | RXRX |
|---|---|---|
| Price | $60.55 | $3.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $68.00 | $7.50 |
| AVG Volume (30 Days) | 596.3K | ★ 14.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.78 | 14.79 |
| EPS | ★ 7.33 | N/A |
| Revenue | ★ $1,480,099,000.00 | $74,681,000.00 |
| Revenue This Year | $5.87 | $12.11 |
| Revenue Next Year | $6.83 | $82.52 |
| P/E Ratio | $7.93 | ★ N/A |
| Revenue Growth | 9.87 | ★ 26.92 |
| 52 Week Low | $46.14 | $2.77 |
| 52 Week High | $83.39 | $7.18 |
| Indicator | BLBD | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.82 | 50.83 |
| Support Level | $59.82 | $2.87 |
| Resistance Level | $62.90 | $3.42 |
| Average True Range (ATR) | 2.27 | 0.18 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 32.36 | 58.46 |
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.